Skip to content
Home
About us
Our Team
Scientific Advisors
Our Product Pipeline
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Home
About us
Our Team
Scientific Advisors
Our Product Pipeline
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Eyestem announces US operations with appointment of Ravi Achar and engagement of Stradling advisors
Home
home_banner
Eyestem announces US operations with appointment of Ravi Achar and engagement of Stradling advisors
Post Author:
eyetem@admin
Post navigation
Previous Post
Eyestem raises Series A round from Biological E, Alkem, NATCO, Kemwell promoters and existing investors- Kotak and Endiya
Next Post
Eyestem bags the top innovator award in the country across all categories at the prestigious Economic Times awards